CD163 and atherosclerosis: One of the selected peptides mimics a putative CD163 homodimerization domain and considering that CD163 has a prominent role in inflammation, this CTHRSSVVC-phage showed overall the strongest reactivity and binding affinity to atherosclerotic lesions and has been validated as a potential marker for atherosclerosis disease progression [20,21].